Jazz Pharmaceuticals plc Operating Cash Flow
Jazz Pharmaceuticals plc (JAZZ) reported Operating Cash Flow of $823.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $415.70M, a 368.13% increase year-over-year.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $408.20M, a 5.03% decline year-over-year.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $362.52M, a 9.05% decline year-over-year.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $474.65M, a 19.04% increase year-over-year.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2025 was $1.36B, a 2.88% decline from fiscal 2024.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2024 was $1.40B, a 27.83% increase from fiscal 2023.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2023 was $1.09B, a 14.15% decline from fiscal 2022.
- Jazz Pharmaceuticals plc net cash provided by (used in) operating activities for fiscal 2022 was $1.27B, a 63.39% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $415.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $823.90M 10-Q · filed 2026-08-03 | $1.19B derived: sum of 3 quarters · filed 2026-08-03 | $1.66B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $408.20M 10-Q · filed 2026-05-05 | $770.72M derived: sum of 2 quarters · filed 2026-05-05 | $1.25B derived: sum of 3 quarters · filed 2026-05-05 | $1.33B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $362.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $837.17M derived: sum of 2 quarters · filed 2026-02-24 | $925.97M derived: sum of 3 quarters · filed 2026-08-03 | $1.36B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $474.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $563.46M derived: sum of 2 quarters · filed 2026-08-03 | $993.25M 10-Q · filed 2025-11-05 | $1.39B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $88.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $518.60M 10-Q · filed 2026-08-03 | $518.64M 10-Q · filed 2025-08-06 | $917.18M derived: sum of 3 quarters · filed 2026-08-03 | $1.32B derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $429.80M 10-Q · filed 2026-05-05 | $429.78M 10-Q · filed 2025-05-07 | $828.38M derived: sum of 2 quarters · filed 2026-05-05 | $1.23B derived: sum of 3 quarters · filed 2026-05-05 | $1.56B derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $398.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $797.33M derived: sum of 2 quarters · filed 2026-02-24 | $1.13B derived: sum of 3 quarters · filed 2026-02-24 | $1.40B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $398.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $730.10M derived: sum of 2 quarters · filed 2025-11-05 | $997.33M 10-Q · filed 2025-11-05 | $1.16B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $331.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $598.58M 10-Q · filed 2025-08-06 | $765.92M derived: sum of 3 quarters · filed 2026-02-24 | $1.07B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $267.23M 10-Q · filed 2025-05-07 | $434.57M derived: sum of 2 quarters · filed 2026-02-24 | $741.76M derived: sum of 3 quarters · filed 2026-02-24 | $1.04B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $167.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $474.53M derived: sum of 2 quarters · filed 2026-02-24 | $771.30M derived: sum of 3 quarters · filed 2026-02-24 | $1.09B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $307.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $603.96M derived: sum of 2 quarters · filed 2024-11-07 | $924.67M 10-Q · filed 2024-11-07 | $1.27B derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $296.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $617.47M 10-Q · filed 2024-08-01 | $959.44M derived: sum of 3 quarters · filed 2025-02-26 | $1.38B derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $320.71M 10-Q · filed 2024-05-02 | $662.68M derived: sum of 2 quarters · filed 2025-02-26 | $1.08B derived: sum of 3 quarters · filed 2025-02-26 | $1.38B derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $341.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $759.96M derived: sum of 2 quarters · filed 2025-02-26 | $1.06B derived: sum of 3 quarters · filed 2025-02-26 | $1.27B 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $417.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $721.03M derived: sum of 2 quarters · filed 2023-11-08 | $930.01M 10-Q · filed 2023-11-08 | $1.11B derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $303.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $512.01M 10-Q · filed 2023-08-09 | $689.77M derived: sum of 3 quarters · filed 2024-02-28 | $963.83M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $208.98M 10-Q · filed 2023-05-10 | $386.73M derived: sum of 2 quarters · filed 2024-02-28 | $660.79M derived: sum of 3 quarters · filed 2024-02-28 | $702.49M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $177.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $451.81M derived: sum of 2 quarters · filed 2024-02-28 | $493.51M derived: sum of 3 quarters · filed 2024-02-28 | $778.51M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $274.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $315.75M derived: sum of 2 quarters · filed 2022-11-09 | $600.75M 10-Q · filed 2022-11-09 | $787.02M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $41.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $326.69M 10-Q · filed 2022-08-03 | $512.96M derived: sum of 3 quarters · filed 2023-03-01 | $770.85M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $285.00M 10-Q · filed 2022-05-04 | $471.27M derived: sum of 2 quarters · filed 2023-03-01 | $729.16M derived: sum of 3 quarters · filed 2023-03-01 | $911.68M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $186.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $444.16M derived: sum of 2 quarters · filed 2023-03-01 | $626.68M derived: sum of 3 quarters · filed 2023-03-01 | $899.65M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $257.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $440.41M derived: sum of 2 quarters · filed 2021-11-09 | $713.38M 10-Q · filed 2021-11-09 | $801.17M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $182.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $455.49M 10-Q · filed 2021-08-03 | $543.29M derived: sum of 3 quarters · filed 2022-03-01 | $880.79M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $272.97M 10-Q · filed 2021-05-04 | $360.77M derived: sum of 2 quarters · filed 2022-03-01 | $698.27M derived: sum of 3 quarters · filed 2022-03-01 | $847.12M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $87.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $425.30M derived: sum of 2 quarters · filed 2022-03-01 | $574.15M derived: sum of 3 quarters · filed 2022-03-01 | $776.40M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $337.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $486.35M derived: sum of 2 quarters · filed 2020-11-02 | $688.60M 10-Q · filed 2020-11-02 | $906.70M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $148.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $351.10M 10-Q · filed 2020-08-04 | $569.20M derived: sum of 3 quarters · filed 2021-02-23 | $790.67M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $202.25M 10-Q · filed 2020-05-05 | $420.35M derived: sum of 2 quarters · filed 2021-02-23 | $641.82M derived: sum of 3 quarters · filed 2021-02-23 | $833.80M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $218.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $439.57M derived: sum of 2 quarters · filed 2021-02-23 | $631.54M derived: sum of 3 quarters · filed 2021-02-23 | $798.90M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $221.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $413.45M derived: sum of 2 quarters · filed 2019-11-05 | $580.81M 10-Q · filed 2019-11-05 | $574.56M 10-Q · filed 2018-11-06 | $785.37M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $191.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $359.33M 10-Q · filed 2019-08-06 | $353.98M 10-Q · filed 2018-08-07 | $563.89M derived: sum of 3 quarters · filed 2020-02-25 | $752.79M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $167.36M 10-Q · filed 2019-05-07 | $162.36M 10-Q · filed 2018-05-08 | $371.92M derived: sum of 2 quarters · filed 2020-02-25 | $560.82M derived: sum of 3 quarters · filed 2020-02-25 | $695.91M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $204.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $393.46M derived: sum of 2 quarters · filed 2020-02-25 | $528.55M derived: sum of 3 quarters · filed 2020-02-25 | $693.09M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $188.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $323.99M derived: sum of 2 quarters · filed 2018-11-06 | $488.53M 10-Q · filed 2018-11-06 | $669.22M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $135.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $299.63M 10-Q · filed 2018-08-07 | $480.33M derived: sum of 3 quarters · filed 2019-02-26 | $613.35M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $164.54M 10-Q · filed 2018-05-08 | $345.24M derived: sum of 2 quarters · filed 2019-02-26 | $478.26M derived: sum of 3 quarters · filed 2019-02-26 | $605.28M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $180.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $313.72M derived: sum of 2 quarters · filed 2019-02-26 | $440.74M derived: sum of 3 quarters · filed 2019-02-26 | $592.39M 10-K · filed 2019-02-26 | $590.54M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $133.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $260.04M derived: sum of 2 quarters · filed 2017-11-07 | $411.70M 10-Q · filed 2017-11-07 | $409.84M 10-Q · filed 2016-11-08 | $531.44M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $127.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $278.67M 10-Q · filed 2017-08-08 | $273.31M 10-Q · filed 2016-08-09 | $398.41M derived: sum of 3 quarters · filed 2018-02-27 | $573.49M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $151.65M 10-Q · filed 2017-05-09 | $143.72M 10-Q · filed 2016-05-10 | $271.39M derived: sum of 2 quarters · filed 2018-02-27 | $446.47M derived: sum of 3 quarters · filed 2018-02-27 | $587.04M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $119.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $294.82M derived: sum of 2 quarters · filed 2018-02-27 | $435.39M derived: sum of 3 quarters · filed 2018-02-27 | $531.94M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $175.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $315.65M derived: sum of 2 quarters · filed 2016-11-08 | $412.20M 10-Q · filed 2016-11-08 | $546.46M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $140.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $237.13M 10-Q · filed 2016-08-09 | $371.39M derived: sum of 3 quarters · filed 2017-02-28 | $501.08M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $96.56M 10-Q · filed 2016-05-10 | $230.82M derived: sum of 2 quarters · filed 2017-02-28 | $360.51M derived: sum of 3 quarters · filed 2017-02-28 | $435.44M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $134.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $263.96M derived: sum of 2 quarters · filed 2017-02-28 | $338.88M derived: sum of 3 quarters · filed 2017-02-28 | $407.61M 10-K · filed 2017-02-28 | $405.76M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $129.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $204.62M derived: sum of 2 quarters · filed 2015-11-09 | $273.34M 10-Q · filed 2015-11-09 | $352.38M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $74.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $143.65M 10-Q · filed 2015-08-05 | $222.68M derived: sum of 3 quarters · filed 2016-02-23 | $353.47M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $68.72M 10-Q · filed 2015-05-07 | $147.76M derived: sum of 2 quarters · filed 2016-02-23 | $278.55M derived: sum of 3 quarters · filed 2016-02-23 | $287.26M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $79.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $209.82M derived: sum of 2 quarters · filed 2016-02-23 | $218.54M derived: sum of 3 quarters · filed 2016-02-23 | $288.43M 10-K · filed 2016-02-23 | $283.62M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $130.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $139.51M derived: sum of 2 quarters · filed 2014-11-04 | $209.40M 10-Q · filed 2014-11-04 | $204.41M 10-Q · filed 2013-11-05 | $313.74M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $78.61M 10-Q · filed 2014-08-05 | $74.61M 10-Q · filed 2013-08-06 | $182.95M derived: sum of 3 quarters · filed 2015-02-24 | $227.10M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $69.89M 10-Q · filed 2014-05-08 | $65.89M 10-Q · filed 2013-05-07 | $174.24M derived: sum of 2 quarters · filed 2015-02-24 | $218.38M derived: sum of 3 quarters · filed 2015-02-24 | $295.35M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $104.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $148.49M derived: sum of 2 quarters · filed 2015-02-24 | $225.46M derived: sum of 3 quarters · filed 2015-02-24 | $249.75M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $44.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $121.11M derived: sum of 2 quarters · filed 2013-11-05 | $145.41M 10-Q · filed 2013-11-05 | $189.07M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $76.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $101.26M 10-Q · filed 2013-08-06 | $144.92M derived: sum of 3 quarters · filed 2014-02-25 | $190.98M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $24.30M 10-Q · filed 2013-05-07 | $67.95M derived: sum of 2 quarters · filed 2014-02-25 | $114.01M derived: sum of 3 quarters · filed 2014-02-25 | $151.44M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $43.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $89.71M derived: sum of 2 quarters · filed 2014-02-25 | $127.15M derived: sum of 3 quarters · filed 2014-02-25 | $151.60M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $46.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $83.49M derived: sum of 2 quarters · filed 2012-11-09 | $107.94M 10-Q · filed 2012-11-09 | $130.73M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $37.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $61.88M 10-Q · filed 2012-08-07 | $84.67M derived: sum of 3 quarters · filed 2013-02-26 | $103.16M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $24.45M 10-Q · filed 2012-05-08 | $47.24M derived: sum of 2 quarters · filed 2013-02-26 | $65.72M derived: sum of 3 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $22.79M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $41.28M derived: sum of 2 quarters · filed 2013-02-26 | $58.87M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $18.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $36.08M 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $17.59M 10-Q · filed 2011-08-03 | |||||||
| 2009-12-31 | -$15.88M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |